skip-to-main

Spikevax JN.1 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine

Spikevax® JN.1 is indicated for active immunisation to prevent COVID‑19 caused by SARS-CoV-2 in individuals 12 years of age and older.

Patient Information Leaflet

Summary of Product Characteristics

Contact Moderna

How can we help you?

Report a Side Effect: Adverse Event Intake Portal
Email Us: WeCare@modernatx.com
Call Us: 8000 3570 4155 Monday - Friday 9:00 AM to 5:00 PM GST (closed holidays)